AzTrials
AzTrials

EmergenciesNCT05597059

The Diagnostic Value of the First Clinical Impression of Patients Presenting to the Emergency Department (PREKEYDIA)

An observational study of Emergencies, run by Kepler University Hospital at 1 site in Austria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Finding a diagnosis for acutely ill patients places high demands on emergency medical personnel. While anamnesis and clinical examination provide initial indications and allow a tentative diagnosis, both laboratory chemistry and imaging tests are used to confirm (or exclude) the tentative diagnosis. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Emergencies
What is being tested?
Machine Learning Prediction
How many people
1,506 participants
Where
1 siteAustria
Study dates
1 Sep 2019to 1 Feb 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Adults presenting to the emergency department.

Who may be able to join

  • Patients presenting to the emergency department between 2019-09-01 and 2020-02-28.

Who cannot join

  • None.

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • Kepler University Hospital

    Linz, Upper Austria, 4021

Other trials in Austria

About this study

Official title: The Diagnostic Value of the First Clinical Impression of Patients Presenting to the Emergency Department

Finding a diagnosis for acutely ill patients places high demands on emergency medical personnel. While anamnesis and clinical examination provide initial indications and allow a tentative diagnosis, both laboratory chemistry and imaging tests are used to confirm (or exclude) the tentative diagnosis. The more precise and targeted the additional laboratory chemical or radiological diagnosis, the more quickly and economically the causal treatment of the emergency patient can be initiated.

One examination modality, which in addition to the medical history and clinical examination, could quickly provide information about the condition of the patient, their clinical picture and severity of illness, is the first clinical impression of the patient (so-called "first impression" or "end-of-bed view"). This describes the first sensory impression that the medical staff gathers from a patient. This includes visual (e.g., facial expression, gait, breathing), auditory (e.g., voice pitch, shortness of breath when speaking), and olfactory (e.g., smell of exhaled air, body odor) impressions. Clinical practice shows that a great deal of important additional information can be gathered through this first clinical impression, which, together with the history and clinical examination of the emergency patient, provides valuable clues to the underlying condition.

To date, however, only scattered data and study results exist in the medical literature on the value of the first clinical impression in the care of emergency patients. In the present prospective observational study, the study attempts to evaluate the predictive value of the first clinical impression in identifying a leading symptom and other important clinical parameters.

Conditions
Emergencies
Being tested
Machine Learning Prediction
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Machine Learning PredictionDiagnostic test

    Machine Learning Prediction

Study groups in NCT05597059
Study groupRoleWhat they receive
Shortness of breathNot described
Receives: Diagnostic Test: Machine Learning Prediction
Extremity pathologiesNot described
Receives: Diagnostic Test: Machine Learning Prediction
Abdominal painNot described
Receives: Diagnostic Test: Machine Learning Prediction
Urological pathologiesNot described
Receives: Diagnostic Test: Machine Learning Prediction
Chest painNot described
Receives: Diagnostic Test: Machine Learning Prediction
Back painNot described
Receives: Diagnostic Test: Machine Learning Prediction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. AUROC for Classification of Shortness of Breath

    AUROC for Classification of Shortness of Breath

    Measured: 2019-09-01 to 2020-02-28

  2. AUROC for Classification of Extremity Pathologies

    AUROC for Classification of Extremity Pathologies

    Measured: 2019-09-01 to 2020-02-28

  3. AUROC for Classification of Abdominal Pain

    AUROC for Classification of Abdominal Pain

    Measured: 2019-09-01 to 2020-02-28

  4. AUROC for Classification of Urological Pathologies

    AUROC for Classification of Urological Pathologies

    Measured: 2019-09-01 to 2020-02-28

  5. AUROC for Classification of Chest Pain

    AUROC for Classification of Chest Pain

    Measured: 2019-09-01 to 2020-02-28

  6. AUROC for Classification of Back Pain

    AUROC for Classification of Back Pain

    Measured: 2019-09-01 to 2020-02-28

Secondary outcomes (3)
  1. AUROC for Classification of Hospital Admission

    AUROC for Classification of Hospital Admission

    Measured: 2019-09-01 to 2020-02-28

  2. Confusion Matrix

    Confusion Matrix Results: true positives, true negatives, false positive, false negatives and values calculated from these results.

    Measured: 2019-09-01 to 2020-02-28

  3. Descriptive Statistics

    Descriptive Statistics (e. g. age in years)

    Measured: 2019-09-01 to 2020-02-28

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2022
  2. Study start1 Sep 2019
  3. Primary completion28 Feb 2020
  4. Study completion1 Feb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,506 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05597059
Sponsor's protocol ID
PREKEYDIA
Status last verified
Oct 2022
First submitted
25 Oct 2022
Last updated
31 Oct 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Emergencies, run by Kepler University Hospital at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

AUROC for Classification of Shortness of Breath (time frame: 2019-09-01 to 2020-02-28). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in